Quick Answer
PTC THERAPEUTICS, INC. reported Operating Income of $866.93 million for fiscal year 2025.
PTC THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $866.93M | +386.5% |
| 2024 | -$302.57M | +31.2% |
| 2023 | -$439.50M | +1.8% |
| 2022 | -$447.41M | -19.5% |
| 2021 | -$374.44M | +13.3% |
| 2020 | -$431.77M | -79.0% |
| 2019 | -$241.16M | -108.5% |
| 2018 | -$115.69M | -79.9% |
| 2017 | -$64.29M | +51.3% |
| 2016 | -$132.06M | +21.0% |
| 2015 | -$167.13M | -68.1% |
| 2014 | -$99.41M | -119.0% |
| 2013 | -$45.40M | -69.3% |
| 2012 | -$26.81M | -187.7% |
| 2011 | $30.58M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.02M | +105.5% | +108.6% |
| June 30, 2025 | -$34.96M | +13.1% | -103.6% |
| March 31, 2025 | $970.23M | +2234.6% | +1879.9% |
| September 30, 2024 | -$54.51M | +53.9% | -35.5% |
| June 30, 2024 | -$40.22M | +80.8% | +11.5% |
| March 31, 2024 | -$45.45M | +61.4% | +61.5% |
| September 30, 2023 | -$118.16M | -73.3% | +43.6% |
| June 30, 2023 | -$209.54M | -126.9% | -78.2% |
- PTC THERAPEUTICS, INC. showed an increase of +386.5% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, PTC THERAPEUTICS, INC.’s operating income has grown by 2734.8% (from $30.58 million to $866.93 million).
- The most recent figure is from PTC THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: